TY - JOUR
T1 - Ectodysplasin pathogenic variants affecting the furin-cleavage site and unusual clinical features define X-linked hypohidrotic ectodermal dysplasia in India
AU - Chaudhary, Ajay Kumar
AU - Gholse, Aishwarya
AU - Nagarajaram, Hampapathalu Adimurthy
AU - Dalal, Ashwin Bhikaji
AU - Gupta, Neerja
AU - Dutta, Atanu Kumar
AU - Danda, Sumita
AU - Gupta, Rekha
AU - Sankar, Hariharan V.
AU - Bhavani, Gandham Sri Lakshmi
AU - Girisha, Katta M.
AU - Phadke, Shubha Rao
AU - Ranganath, Prajnya
AU - Bashyam, Murali Dharan
N1 - Funding Information:
We are extremely thankful to all patients, their family members, and control subjects for kindly consenting to be a part of the study. We thank Mr Rajkishore Mohapatra for initial work on sequence and structure analysis of the pathogenic variants detected in this study. The study was supported by a core grant from the Department of Biotechnology, Ministry of Science and Technology, Government of India to CDFD. Hampapathalu Adimurthy Nagarajaram and Aishwarya Gholse gratefully acknowledge the core start‐up grant from the University of Hyderabad.
Publisher Copyright:
© 2021 Wiley Periodicals LLC.
PY - 2022/3
Y1 - 2022/3
N2 - Hypohidrotic ectodermal dysplasia (HED) is a rare genetic disorder caused by mutational inactivation of a developmental pathway responsible for generation of tissues of ectodermal origin. The X-linked form accounts for the majority of HED cases and is caused by Ectodysplasin (EDA) pathogenic variants. We performed a combined analysis of 29 X-linked hypohidrotic ectodermal dysplasia (XLHED) families (including 12 from our previous studies). In addition to the classical triad of symptoms including loss (or reduction) of ectodermal structures, such as hair, teeth, and sweat glands, we detected additional HED-related clinical features including facial dysmorphism and hyperpigmentation in several patients. Interestingly, global developmental delay was identified as an unusual clinical symptom in many patients. More importantly, we identified 22 causal pathogenic variants that included 15 missense, four small in-dels, and one nonsense, splice site, and large deletion each. Interestingly, we detected 12 unique (India-specific) pathogenic variants. Of the 29 XLHED families analyzed, 11 (38%) harbored pathogenic variant localized to the furin cleavage site. A comparison with HGMD revealed significant differences in the frequency of missense pathogenic variants; involvement of specific exons and/or protein domains and transition/transversion ratios. A significantly higher proportion of missense pathogenic variants (33%) localized to the EDA furin cleavage when compared to HGMD (7%), of which p.R155C, p.R156C, and p.R156H were detected in three families each. Therefore, the first comprehensive analysis of XLHED from India has revealed several unique features including unusual clinical symptoms and high frequency of furin cleavage site pathogenic variants.
AB - Hypohidrotic ectodermal dysplasia (HED) is a rare genetic disorder caused by mutational inactivation of a developmental pathway responsible for generation of tissues of ectodermal origin. The X-linked form accounts for the majority of HED cases and is caused by Ectodysplasin (EDA) pathogenic variants. We performed a combined analysis of 29 X-linked hypohidrotic ectodermal dysplasia (XLHED) families (including 12 from our previous studies). In addition to the classical triad of symptoms including loss (or reduction) of ectodermal structures, such as hair, teeth, and sweat glands, we detected additional HED-related clinical features including facial dysmorphism and hyperpigmentation in several patients. Interestingly, global developmental delay was identified as an unusual clinical symptom in many patients. More importantly, we identified 22 causal pathogenic variants that included 15 missense, four small in-dels, and one nonsense, splice site, and large deletion each. Interestingly, we detected 12 unique (India-specific) pathogenic variants. Of the 29 XLHED families analyzed, 11 (38%) harbored pathogenic variant localized to the furin cleavage site. A comparison with HGMD revealed significant differences in the frequency of missense pathogenic variants; involvement of specific exons and/or protein domains and transition/transversion ratios. A significantly higher proportion of missense pathogenic variants (33%) localized to the EDA furin cleavage when compared to HGMD (7%), of which p.R155C, p.R156C, and p.R156H were detected in three families each. Therefore, the first comprehensive analysis of XLHED from India has revealed several unique features including unusual clinical symptoms and high frequency of furin cleavage site pathogenic variants.
UR - http://www.scopus.com/inward/record.url?scp=85120486166&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85120486166&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.62579
DO - 10.1002/ajmg.a.62579
M3 - Article
AN - SCOPUS:85120486166
SN - 1552-4825
VL - 188
SP - 788
EP - 805
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 3
ER -